SDS Biotech K.K. Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2014; Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2014; Provides Dividend Guidance for the Full Year Ending December 31, 2014
The company provided consolidated earnings guidance for the full year ending December 31, 2014. For the year, the company expects to report net sales of ¥14,866 million, operating income of ¥1,352 million, ordinary income of ¥1,179 million and net income of ¥684 million or ¥87.35 per share.
The company also provided dividend guidance for the full year ending December 31, 2014. For the year, the company expects year end dividend of JPY 10.00 per share. The company paid year end dividend of JPY 10.00 per share for the year ended March 31, 2013.